Related Experiment Video
Updated: Jan 12, 2026
08:01
The Soft Agar Colony Formation Assay
Published on: October 27, 2014
113.5K
Targeting Wnt/β-Catenin Pathway by DNA Alkylating Pyrrole-Imidazole Polyamide in Colon Cancer
Osamu Shimozato1,2, Natsue Akao1, Yoko Yanagisawa1
1Laboratory of Precision Tumor Model Systems, Chiba Cancer Center Research Institute, Chiba, Japan.
Cancer Science
|November 5, 2025
Summary
A new drug candidate, WNT-Chb, effectively targets the Wnt/β-catenin pathway in colon cancer. This compound suppressed tumor growth in vitro and in vivo, showing promise for treating this cancer type.
Area of Science:
- Oncology
- Molecular Biology
- Drug Discovery
Background:
- The Wnt/β-catenin pathway is crucial in carcinogenesis, regulating cancer cell proliferation and differentiation.
- This pathway is controlled by T cell factor/lymphocyte enhancer factor (TCF/LEF) transcription factors.
- Inhibiting this pro-oncogenic pathway presents a potential anti-cancer therapeutic strategy.
Purpose of the Study:
- To synthesize and evaluate a novel polyamide, WNT-Chb, as an anti-cancer agent.
- To investigate the anti-cancer effects of WNT-Chb on colon cancer cells.
- To assess WNT-Chb's mechanism of action involving the Wnt/β-catenin pathway.
Main Methods:
- Synthesis of a novel polyamide (WNT-Chb) incorporating N-methylpyrrole, N-methylimidazole, and chlorambucil.
- In vitro and in vivo studies using colon cancer cell models.
- Analysis of WNT-Chb binding to TCF/LEF-responsive elements and its effect on Wnt-target gene expression.
Main Results:
- WNT-Chb demonstrated preferential binding to the TCF/LEF-responsive element (5'-CCTTTGA-3').
- The compound suppressed the expression of multiple Wnt-target genes.
- WNT-Chb significantly attenuated colon cancer cell proliferation in vitro and tumor growth in vivo.
Conclusions:
- WNT-Chb acts as an inhibitor of the Wnt/β-catenin pathway.
- The novel polyamide WNT-Chb exhibits significant anti-cancer effects against colon cancer.
- WNT-Chb is a promising drug candidate for Wnt/β-catenin pathway-dependent colon cancers.
Keywords:
TCF/LEF transcription factorWnt/β‐catenin pathwayanti‐cancer activitychlorambucil‐conjugated pyrrole‐imidazole polyamidecolon cancerMore Related Videos
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.8K
10:13A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
Published on: July 3, 2013
11.6K
Related Concept Videos
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:54Canonical Wnt Signaling Pathway
10.4K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.4K
01:41Non-Canonical Wnt Signaling Pathways
8.2K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.2K
02:36DNA Damage can Stall the Cell Cycle
10.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.0K
02:07Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K